Are Enterococcus faecalis and Streptococcus agalactiae considered normal urinary flora, or do they indicate a urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Enterococcus faecalis and Streptococcus agalactiae Are NOT Normal Urinary Flora

Neither Enterococcus faecalis nor Streptococcus agalactiae are considered normal urinary flora—their presence in urine culture indicates potential urinary tract infection and requires clinical correlation with symptoms and pyuria to determine significance.

Understanding the Clinical Context

The urinary tract is not sterile, but these organisms are recognized uropathogens, not commensals. According to current guidelines, the diagnosis of UTI requires three components 1:

  • Acute-onset urinary symptoms (dysuria, urgency, frequency, hematuria)
  • Pyuria (>5 WBC/hpf on microscopic urinalysis)
  • Laboratory detection of a uropathogen

While E. coli dominates (75-95% of cases), other pathogens including Enterobacteriaceae and gram-positive organisms like enterococci and streptococci are well-established causes of UTI 1.

Enterococcus faecalis as a Uropathogen

E. faecalis is definitively pathogenic in the urinary tract:

  • Second most frequent bacteria (16%) detected in suspected UTI in male outpatients 2
  • Particularly common in young men (17%) and in polymicrobial infections (47% of suspected UTI in men) 2
  • Associated with higher recurrence rates (22-28%) compared to E. coli, with recurrence increasing with age 2
  • Even low colony counts (10,000-100,000 CFU/ml) can represent true UTI when accompanied by leukocyturia and symptoms—over 54% of such cases are true infections 3

Critical pitfall: More than half of patients with enterococcal counts below the traditional 100,000 CFU/ml threshold may have true UTI, especially if hospitalized with dysuria, urgency, or frequency 3. Do not dismiss low-count enterococcal growth reflexively.

Streptococcus agalactiae (Group B Streptococcus) as a Uropathogen

S. agalactiae is a recognized uropathogen in both sexes:

  • Causes UTI in males and non-pregnant females when isolated at ≥10⁵ CFU/ml with clinical signs and pathologic urinary sediment 4
  • Listed among gram-positive uropathogens alongside S. saprophyticus and E. faecalis 5
  • Can be easily overlooked due to limited culture-based assays in routine microbiology laboratories 5

Clinical Decision Algorithm

When you encounter these organisms in urine culture:

  1. Assess symptoms: Look for dysuria, urgency, frequency, suprapubic pain, flank pain, fever
  2. Check urinalysis: Confirm pyuria (>5 WBC/hpf)
  3. Consider colony count: Even counts of 10,000-100,000 CFU/ml can be significant for enterococci 3
  4. Evaluate risk factors: Hospitalization, catheterization, age, diabetes, structural abnormalities 6

If symptoms + pyuria + organism present = Treat as UTI

If asymptomatic bacteriuria (no symptoms) = Do not treat unless before traumatic urologic procedures 6

Treatment Considerations

For complicated UTI with these organisms, guidelines recommend 6:

  • Amoxicillin plus aminoglycoside, OR
  • Second-generation cephalosporin plus aminoglycoside, OR
  • IV third-generation cephalosporin

Avoid empiric ciprofloxacin for enterococcal UTI in older men—resistance increases from 22% (ages 18-29) to 37% (≥70 years) 2. Ciprofloxacin should only be used if local resistance <10% 6.

Key Takeaway

The presence of E. faecalis or S. agalactiae in urine culture signals potential infection, not colonization. These are established uropathogens requiring the same diagnostic rigor as E. coli: symptoms, pyuria, and appropriate colony counts. The evolving understanding of the urinary microbiome does not change the pathogenic potential of these organisms 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.